Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vladimira Rimac has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Ines Bojanić

    Department of Transfusion Medicine and Transplantation Biology University Hospital Center Zagreb Zagreb Croatia

    3 shared publications
  • Branka Golubić Ćepulić

    Clinical Department of Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia

    2 shared publications
  • Ines Bojanić

    Clinical Department of Transfusion Medicine and Transplantation Biology University Hospital Centre Zagreb Zagreb Croatia

    2 shared publications
  • Jasna Lenicek Krleza

    Department of Laboratory Diagnostics, Children’s Hospital Zagreb, Zagreb, Croatia

    2 shared publications
  • Jelena Vlasic Tanaskovic

    Department of Laboratory Diagnostics, General Hospital Pula, Pula, Croatia

    2 shared publications
  • Koraljka Gojčeta

    University Hospital Centre Zagreb, Department for Transfusion Medicine and Transplantation Biology, Croatian Tissue and Cell Bank, Human Milk Bank

    2 shared publications

Latest Publications

  • Open Access

    Short-Term In Vitro Exposure of Human Blood to 5G Network Frequencies: Do Sex and Frequency Additionally Affect Erythrocyte Morphometry?

    by Nikolino Žura, Silvijo Vince, Porin Perić, Marinko Vilić, Krešimir Malarić, Vladimira Rimac, Branka Golubić Ćepulić, Marina Vajdić, Ivan Jurak, Suzana Milinković Tur, et al.

    Background/Objectives: This study assessed the effects of 5G radiofrequency electromagnetic radiation (RF-EMR) at different frequencies (700 MHz, 2500 MHz, 3500 MHz) on the complete blood count (CBC), erythrocyte morphometry, and platelet activation after the short-term in vitro exposure of human blood. Methods: Blood samples from 30 healthy volunteers (15 men and 15 women, aged 25–40 years old) were collected at three intervals (14 days apart). For each collection, four tubes of blood were drawn per volunteer—two experimental and two controls. Experimental samples were exposed to 5G RF-EMR for 2 h at room temperature using a half-cone gigahertz transverse electromagnetic cell. The CBC was analysed via a haematology analyser, the erythrocyte morphometry was analysed using the SFORM program, and platelet activation was analysed via flow cytometry. Results: The CBC and platelet activation showed no significant differences between the experimental and control samples. However, the erythrocyte morphometry exhibited notable changes. At 700 MHz, the erythrocyte size, contour, and membrane roughness increased significantly for both sexes, with women’s cells showing greater sensitivity. At 2500 MHz, women exhibited an increased contour index and a decreased solidity and form factor. At 3500 MHz, women showed an increased contour index and outline but a decreased solidity, elongation, and form factor. Cluster analysis identified two erythrocyte subpopulations: smaller, rounder cells with smooth membranes and larger cells with rougher membranes. Conclusions: These results indicate that 5G RF-EMR exposure significantly alters erythrocyte morphometry. The strongest effects were observed at 700 MHz, where men exhibited greater membrane roughness, and women showed larger and rounder erythrocytes. These findings suggest that short-term in vitro 5G RF-EMR exposure disrupts the cytoskeleton, increasing membrane permeability and deformability.


  • Open Access

    The impact of cryoprotectant exposure time on post-thaw viability of autologous and allogeneic hematopoietic stem cells and leukocyte subpopulations

    by Vladimira Rimac, Ines Bojanić, Sanja Dabelić, Branka Golubić Ćepulić

    Although the use of cryoprotectant dimethyl sulfoxide (DMSO) is the gold standard in cryopreservation of hematopoietic stem cells, it is well known that it has a negative effect on cell viability. The aim of this prospective study was to examine how the length of post-thaw exposure to DMSO affects the cell viability and stability of peripheral blood stem cell (PBSC) samples. Additionally, the effects of donor type and pre-cryopreservation storage time on post-thaw viability during the stability study were evaluated. In 30 autologous and 30 allogeneic PBSC samples viable CD34+, CD14+, CD19+, CD16+/56+, and CD3+ cells were determined immediately after thawing, and one-and three-hours post-thaw. Analysis of the absolute count of viable cells in thawed samples showed a significant difference between all measurement points for CD34+ ( p < 0.001), CD14+ ( p < 0.001), and CD19+ cells ( p < 0.001). No significant differences were observed for post-thaw stability of allogeneic samples analysed between products stored before cryopreservation ≥ 24 hours (N = 20), and those stored < 24 hours (N = 10), except for viable CD3+/CD4+ cells after three hours post-thaw ( p = 0.028). In conclusion, DMSO had different effects on leukocyte subpopulations in cryopre-served PBSC samples. The type of donors and the length of storage before cryopreservation did not affect the post-thaw stability of cryopreserved PBSC samples.


  • Role of flow cytometry in evaluation of the cellular therapy products used in haematopoietic stem cell transplantation

    by Vladimira Rimac, Ines Bojanić

    Cellular therapy nowadays includes various products from haematopoietic stem cells (HSC) collected from bone marrow, peripheral blood, and umbilical cord blood to more complex adoptive immune therapy for the treatment of malignant diseases, and gene therapy for inherited immune deficiencies. Broader utilization of cellular therapy requires extensive quality testing of these products that should fulfil the same requirements regarding composition, purity, and potency nevertheless they are manufactured in various centres. Technical improvements of the flow cytometers accompanied by the increased number of available reagents and fluorochromes used to conjugate monoclonal antibodies, enable detailed and precise insight into the function of the immune system and other areas of cell biology, and allows cell evaluation based on size, shape, and morphology or assessment of cell surface markers, as well as cell purity and viability, which greatly contributes to the development and progress of the cell therapy. The aim of this paper is to give an overview of the current use and challenges of flow cytometry analysis in quality assessment of cellular therapy products, with regard to basic principles of determining HSC and leukocyte subpopulation, assessment of cells viability and quality of thawed cryopreserved HSC as well as the importance of validation and quality control of flow cytometry methods according to good laboratory practice.


  • Open Access

    Interpretative comments - need for harmonization? Results of the Croatian survey by the Working Group for Post-analytics

    by Anja Jokic, Jelena Vlasic Tanaskovic, Lorena Honovic, Jasna Lenicek Krleza, Sonja Podolar, Vladimira Rimac

    Interpretation of laboratory test results is a complex post-analytical activity that requires not only understanding of the clinical significance of laboratory results but also the analytical phase of laboratory work. The aims of this study were to determine: 1) the general opinion of Croatian medical biochemistry laboratories (MBLs) about the importance of interpretative comments on laboratory test reports, and 2) to find out whether harmonization of interpretative comments is needed. This retrospective study was designed as a survey by the Working Group for Post-analytics as part of national External Quality Assessment (EQA) program. All 195 MBLs participating in the national EQA scheme, were invited to participate in the survey. Results are reported as percentages of the total number of survey participants. Out of 195 MBLs, 162 participated in the survey (83%). Among them 59% MBLs implemented test result comments in routine according to national recommendations. The majority of laboratories (92%) state that interpretative comments added value to the laboratory reports, and a substantial part (72%) does not have feedback from physicians on their significance. Although physicians and patients ask for expert opinion, participants stated that the lack of interest of physicians (64%) as well as the inability to access patient’s medical record (62%) affects the quality of expert opinion. Although most participants state that they use interpretative comments and provide expert opinions regarding test results, results of the present study indicate that harmonization for interpretative comments is needed.


  • Open Access

    110 OPENING OF THE FIRST HUMAN MILK BANK IN CROATIA

    by Branka Golubić Ćepulić, Anita Pavičić Bošnjak, Ivana Leskovar, Jurjana Novoselac, Koraljka Gojčeta, Vladimira Rimac, Ines Bojanić, Sanja Mazić

    Objective Foundation project for the first human milk banks (HMB) in Croatia was launched in 2017 as the result of a collaboration between the Ministry of Health, University Hospital Centre (UHC) Zagreb, UNICEF and the Croatian Association of Breastfeeding Support Groups. The HMB was opened in UHC Zagreb on November 15, 2019as a part of the Croatian Tissue and Cell Bank, a division of the Department of Transfusion Medicine and Transplantation Biology. The specific technical side is based on the PATH standards and Guide to the quality and safety of tissues and cells for human application, Council of Europe. On January 10, 2020, HMB passed a Competent Authority (CA) inspection, conducted in accordance with the requirements of national tissue legislation that has been adapted to EU Directive 2004/23/EC on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. The specific technical part is based on the PATH standards and Guide to the quality and safety of tissues and cells for human application, Council of Europe. The aim of this study was to review the very first experience in human milk banking in Croatia. Methods We retrospectively analysed the data of the first 28 human milk donors. Results From the opening to mid-February, 135 women showed interest in donating human milk, of which 28 became donors. In February 2020, we had 24 still active donors. Four women stopped donating, with a median donation period of 2 months. All donors were tested for blood borne viruses by serology and NAT and were negative. In total, we received 79 L of donated human milk.We started pasteurizing the milk after obtaining a license. Of the 30 controlled pre-pasteurization milk pools, 10% was over the allowed microbial contamination. Microbiological controls were performed for each pasteurization cycle. They were all sterile. The nutritional values of milk were all within the expected range. Conclusions Human milk is recognised as the optimal feeding for all newborn infants. When mothers’ own milk is not available, donor human milk provided by HMB is the second-best choice, especially for premature or sick infants. The opening of the HMB in Croatia is highly important in helping to provide the best possible medical care for prematurely born babies and infants with a serious medical condition when they cannot receive their mother’s milk.

  • Evaluation of the BD Stem Cell Enumeration Kit on the BD FACSCanto II flow cytometer using bd facscanto clinical and bd facsdiva software

    by Vladimira Rimac, Ines Bojanić, Koraljka Gojčeta, Branka Golubić Ćepulić

    Introduction CD34+ hematopoietic stem cell (HSC) enumeration by cell flow cytometry is routinely used in clinical laboratories for monitoring of HSC mobilization into peripheral blood and assessment of the quality of HSC products. The modified ISHAGE protocol is the most often used procedure for determination of CD34+ cells using flow cytometry. The aim of this study was to evaluate BD Enumeration stem cell kit on flow cytometer BD facscanto II, using facscanto clinical and facsdiva softwares. Methods Validation study included determination of within‐run and between‐run precision, trueness (bias), comparison of the test results analyzed on facscanto clinical and facsdiva softwares, assessment of linearity, specimen stability, and carryover. Results For between‐run precision, coefficients of variation (CVs) were all P = .044) in absolute count of CD34+ cells after 24 hours of storage, when using facscanto clinical software. Conclusion BD Stem Cell Enumeration Kit can be used in routine laboratory work on BD FACSCanto II instrument, whereas facscanto clinical and facsdiva software were used for acquisition and data analysis.


  • Open Access

    General position of Croatian medical biochemistry laboratories on autovalidation

    by Vladimira Rimac, Anja Jokic, Sonja Podolar, Jelena Vlasic Tanaskovic, Lorena Honovic, Jasna Lenicek Krleza

    Introduction: Autovalidation (AV) is an algorithm based on predefined rules designed, among others, to automate and standardize the postanalytical phase of laboratory work. The aim of this study was to examine the overall opinion of Croatian medical biochemistry laboratories regarding various aspects of AV. Material and methods: This retrospective study is an analysis of the responses of a survey about AV comprised of 18 questions, as part of Module 10 (“Postanalytical phase of laboratory testing”) of national External Quality Assessment program, administered by the Croatian Centre for Quality Assessment in Laboratory Medicine. Results were reported as percentages of total number of participants in survey or as proportions of observed data if the overall number of data was <100. Results: 121 laboratories responded to the survey, of which 76% do not use AV, while 11% of laboratories use AV in routine laboratory work. 16/29 laboratories implemented semi-automated AV for general biochemistry (7/29), haematology (5/29), and coagulation (4/29) tests. Analytical measurement ranges, critical values, flags from analysers, interference indices and delta check were the most commonly used rules in the algorithm. 12/29 laboratories performed validation of AV with less than 500 samples (8/29). 7/13 laboratories report the percentage of AV being 20-50%, while 10/13 answered that introduction of AV significantly reduced turnaround time (TAT) (for 20 - 25%), especially for biochemistry tests. Conclusions: Despite of its numerous benefits (i.e. shorter TAT, less manual validation, standardization of the postanalytical phase), only a small number of Croatian laboratories use AV.


  • Implementation of the Autovalidation Algorithm for Clinical Chemistry Testing in the Laboratory Information System

    by Vladimira Rimac, Ivana Lapic, Kresimir Kules, Dunja Rogic, Marijana Miler

    Autovalidation algorithm should be properly designed with clearly defined criteria and any data that do not meet the criteria, must be reviewed and manually validated. The aim was to define the rules for autovalidation in our laboratory information system (LIS), and validate the algorithm prior to its implementation in routine laboratory work. Autovalidation was implemented for all routine serum biochemistry tests. The algorithm included analytical measurement ranges (AMR), delta check, critical values, serum indices and all preanalytical and analytical flags from the analyzer. In the validation process 9805 samples were included, and 78.3% (7677) of all samples were autovalidated. The highest percentage of non-validated samples (54.9%) refers to those with at least one result outside the method linearity ranges (AMR criteria) while critical values were observed to be the least frequent criterion for stopping autovalidation (1.8%). Also, 38 samples were manually validated as they failed to meet the autovalidation criteria. Implementation of algorithm for autovalidation in our institution resulted in the redesign of the existing LIS. This model of the autovalidation algorithm significantly decreased the number of manually validated test results and can be used as a model for introducing autovalidation in other laboratory settings.